| Human papillomavirus and survival of patients with oropharyngeal cancer KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ... New England Journal of Medicine 363 (1), 24-35, 2010 | 7311 | 2010 |
| Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ... The Lancet 393 (10166), 40-50, 2019 | 1282 | 2019 |
| Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 KK Ang, Q Zhang, DI Rosenthal, PF Nguyen-Tan, EJ Sherman, RS Weber, ... Journal of clinical oncology 32 (27), 2940-2950, 2014 | 903 | 2014 |
| Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 N Lee, J Harris, AS Garden, W Straube, B Glisson, P Xia, W Bosch, ... Journal of clinical oncology 27 (22), 3684-3690, 2009 | 818 | 2009 |
| Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer ML Gillison, Q Zhang, R Jordan, W Xiao, WH Westra, A Trotti, S Spencer, ... Journal of clinical oncology 30 (17), 2102-2111, 2012 | 574 | 2012 |
| Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma C Fakhry, Q Zhang, PF Nguyen-Tan, D Rosenthal, A El-Naggar, ... Journal of clinical oncology 32 (30), 3365-3373, 2014 | 567 | 2014 |
| Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of … BL Eisenberg, J Harris, CD Blanke, GD Demetri, MC Heinrich, JC Watson, ... Journal of surgical oncology 99 (1), 42-47, 2009 | 559 | 2009 |
| p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma CH Chung, Q Zhang, CS Kong, J Harris, EJ Fertig, PM Harari, D Wang, ... Journal of clinical oncology 32 (35), 3930-3938, 2014 | 454 | 2014 |
| Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22) A Eisbruch, J Harris, AS Garden, CKS Chao, W Straube, PM Harari, ... International Journal of Radiation Oncology* Biology* Physics 76 (5), 1333-1338, 2010 | 453 | 2010 |
| Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck SA Spencer, J Harris, RH Wheeler, M Machtay, C Schultz, W Spanos, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2008 | 389 | 2008 |
| Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and … CJ Langer, J Harris, EM Horwitz, N Nicolaou, M Kies, W Curran, S Wong, ... Journal of Clinical Oncology 25 (30), 4800-4805, 2007 | 379 | 2007 |
| Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation … WG Kraybill, J Harris, IJ Spiro, DS Ettinger, TF DeLaney, RH Blum, ... Journal of clinical oncology 24 (4), 619-625, 2006 | 324 | 2006 |
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group B Lacas, A Carmel, C Landais, SJ Wong, L Licitra, JS Tobias, B Burtness, ... Radiotherapy and Oncology 156, 281-293, 2021 | 312 | 2021 |
| Institutional clinical trial accrual volume and survival of patients with head and neck cancer EJ Wuthrick, Q Zhang, M Machtay, DI Rosenthal, PF Nguyen-Tan, A Fortin, ... Journal of Clinical Oncology 33 (2), 156-164, 2015 | 272 | 2015 |
| Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer JJ Beitler, Q Zhang, KK Fu, A Trotti, SA Spencer, CU Jones, AS Garden, ... International Journal of Radiation Oncology* Biology* Physics 89 (1), 13-20, 2014 | 262 | 2014 |
| RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck SA Spencer, J Harris, RH Wheeler, M Machtay, C Schultz, W Spanos, ... International Journal of Radiation Oncology* Biology* Physics 51 (5), 1299-1304, 2001 | 236 | 2001 |
| Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234 PM Harari, J Harris, MS Kies, JN Myers, RC Jordan, ML Gillison, RL Foote, ... Journal of Clinical Oncology 32 (23), 2486, 2014 | 231 | 2014 |
| Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the … AS Garden, J Harris, EE Vokes, AA Forastiere, JA Ridge, C Jones, ... Journal of Clinical Oncology 22 (14), 2856-2864, 2004 | 226 | 2004 |
| Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14 KK Ang, J Harris, AS Garden, A Trotti, CU Jones, L Carrascosa, JD Cheng, ... Journal of Clinical Oncology 23 (13), 3008-3015, 2005 | 217 | 2005 |
| Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02 AH Russell, J Harris, PJ Rosenberg, WT Sause, BJ Fisher, JP Hoffman, ... International Journal of Radiation Oncology* Biology* Physics 46 (2), 313-322, 2000 | 217 | 2000 |
